[Short review of pathophysiology and therapeutic possibilities in onchocerciasis with reference to a case report].
We report the first case of onchocerciasis in Austria in a African patient who was admitted to hospital for psychiatric reasons initially. The clinical diagnosis was confirmed by skin-snip examination and staining of the microfilariae. Pathophysiology and therapeutic possibilities are discussed.
Winkler
S
S
Abteilung für Infektionen und Chemotherapie, Universitätsklinik für Innere Medizin I, Wien.
Wenisch
C
C
Wiesinger
E
E
Breyer
S
S
Graninger
W
W
D000328:Adult; D000818:Animals; D000909:Antibodies, Helminth / Q000032:analysis; D004049:Diethylcarbamazine / Q000008:administration & dosage* / Q000009:adverse effects; D004359:Drug Therapy, Combination; D004802:Eosinophilia / Q000276:immunology; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis; D007559:Ivermectin / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D008842:Microfilariae / Q000187:drug effects; D017181:Onchocerca volvulus / Q000187:drug effects* / Q000276:immunology; D009855:Onchocerciasis / Q000188:drug therapy* / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
D000909:Antibodies, Helminth; D007073:Immunoglobulin E; D007559:Ivermectin; D004049:Diethylcarbamazine
Kurze Ubersicht über Pathophysiologie und Therapiemöglichkeiten der Onchozerkose anhand eines Fallberichtes.